Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
I’d certainly have it on a day that people can get to it the strikes have been announced for a few days and looking at the board a few were able to make it but not now and are they holding it at PH so they won’t have to answer awkward questions ?? And as for consolidation having PH as advisors and brokers hasn’t turned out a great idea after all imho the attention to detail is what this company lacks
With the dropping sp weekly we’re are in the territory of a possible hostile takeover imho we still have 737 1801/1802 and others in the pipeline so would be worth a punt and cheap so the question is who’s working for who ??
https://r.search.yahoo.com/_ylt=AwrkLg4e8XJjfkEFTAV0g81Q;_ylu=Y29sbwNpcjIEcG9zAzEEdnRpZAMEc2VjA3Ny/RV=2/RE=1668506014/RO=10/RU=https%3a%2f%2fwww.cdc.gov%2frsv%2fabout%2fsymptoms.html/RK=2/RS=arBhkuPCPSSDigdi.wW67o_thnw-
Could 1801 be used for this ??? With covid ,flu and this apparently causing quite a few problems and all to do with the immune system ,we did so ok for the test with covid just putting it out there
GLA
Until SAR release what exactly has gone wrong if we don’t get CTA or out of the blue we get it in the next week and a half that’s if we were granted 14 days it is all speculation and let’s face it weve all been wrong over a few things on here but each day no RNS the price is dropping
GLA
Still a bump to go depending on the next RNS as to the extent of the CTA either we have to totally resubmit and new timeline or we have the 14 days to get it sorted could still be a canny drop to go depending on the outcome .737 news in jan might be our next news for a rise once we get it back fingers crossed science hasn’t let us down so far just the people who submitted the CTA maybe the re rate will be 2023 and the big question now will be if we are able to do a PH1b in 2023 or will it be 2024 with time scales slipping again
GLA
SOG I think what makes it worse is the fact you have put a template up on what is needed to complete a CTA and even then they have failed with the submission . They must be bricking the AGM as no doubt some very awkward questions will be asked and I think Tim said during the last investor meet he was very happy with the role of peel hunt and maybe just maybe they have been working on a deal and the CTA fiasco has knocked all this back till it’s sorted or maybe wishful thinking
Science hasn’t changed but confidence in the company has
GLA
Due to uncertainties around the timeline for resubmission, we therefore no longer expect the trial to commence before the end of 2022.
Imho they know they will not get approval otherwise they would of had 14 days to re submit with the additional information required we are going nowhere this year except down and like someone said back to a penny share let’s hope 2023 will be better than this S@@t year starting from Jan when we have 737 back and hopefully a completed CTA, PH gone along with Parker no doubt with a price drop we could see either another consolidation or a hostile take over no news for a few weeks not good